Lowe Christopher P.
- SEC CIK
- 0001376260
No open-market purchases or sales filed in the past year.
Current role at each company
- VINC Vincerx Pharma, Inc.Directoras of Aug 26, 2022
- QNCX Quince Therapeutics, Inc.Interim CEO, COO & CFOas of Mar 4, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Lowe Christopher P. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VINC Vincerx Pharma, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 26, 2022 (view filing) | Aug 24-25 | 2 days | Lowe Christopher P.Director | PPurchase | +30.0K | $1.65 | +$49.5K | +300.0%40.0K after | 2 lots |
QNCX Quince Therapeutics, Inc.
Interim CEO, COO & CFO2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2021 (view filing) | Aug 16 | 2 days | Lowe Christopher P.COO & Chief Financial Officer | SSale | −22.0K | $95.31 | −$2.10M | −42.3%30.0K after | 5 lots |
| Oct 7, 2021 (view filing) | Oct 5 | 2 days | Lowe Christopher P.COO & Chief Financial Officer | SSale | −4.96K | $98.50 | −$488.9K | −7.6%60.0K after |